Warning: This security is no longer trading.
Roche completes deal to acquire Foundation Medicine
Foundation Medicine, Inc. (FMI): Price and Financial Metrics
FMI Price/Volume Stats
| Current price | $136.95 | 52-week high | $137.20 |
| Prev. close | $137.00 | 52-week low | $31.70 |
| Day low | $136.95 | Volume | 2,500 |
| Day high | $136.95 | Avg. volume | 459,782 |
| 50-day MA | $121.28 | Dividend yield | N/A |
| 200-day MA | $80.31 | Market Cap | 5.09B |
FMI Stock Price Chart Interactive Chart >
Foundation Medicine, Inc. (FMI) Company Bio
Foundation Medicine provides various molecular information products in the United States. Its molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care, and offers genomic information about each patients individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted oncology therapies. The company was founded in 2009 and is based in Cambridge, Massachusetts.
FMI Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...